Clinical Study
Prevalence of Anemia and Related Deficiencies in the First Year following Laparoscopic Gastric Bypass for Morbid Obesity
Table 4
12 Month evaluation of all RYGB patients.
| | | Month 6 (%) | Month 12 (%) | Total (%) |
| | Anemia | | 50 (13.3%) | 71 (18.8%) | 93 (24,7%) | | MCV | Micro | 24 (6.4%) | 20 (5.3%) | 34 (9.0%) | | Macro | 4 (1.1%) | 6 (1.6%) | 8 (2.1%) | | Elevated TYBC | | 17 (4.5%) | 26 (6.9%) | 32 (8.5%) | | Iron deficiency | | 79 (21%) | 78 (20.7%) | 124 (32.9%) | | Folic acid deficiency | | 34 (9.0%) | 25 (6.6%) | 51 (13.6%) | | Vitamin B12 deficiency | | 89 (23.6%) | 71 (18.8%) | 152 (40.2%) | | Total deficiency | | 175 (46.4%) | 150 (39.8%) | 239 (63.4%) |
|
|
T6 = laboratory findings (%) at 6 months, T12 = laboratory findings (%) at 12 months. .
|
